1. Home
  2. GRNQ vs TXMD Comparison

GRNQ vs TXMD Comparison

Compare GRNQ & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRNQ
  • TXMD
  • Stock Information
  • Founded
  • GRNQ 2013
  • TXMD 2008
  • Country
  • GRNQ Malaysia
  • TXMD United States
  • Employees
  • GRNQ N/A
  • TXMD N/A
  • Industry
  • GRNQ EDP Services
  • TXMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRNQ Technology
  • TXMD Health Care
  • Exchange
  • GRNQ Nasdaq
  • TXMD Nasdaq
  • Market Cap
  • GRNQ 11.3M
  • TXMD 12.3M
  • IPO Year
  • GRNQ 2018
  • TXMD N/A
  • Fundamental
  • Price
  • GRNQ $1.39
  • TXMD $1.23
  • Analyst Decision
  • GRNQ
  • TXMD
  • Analyst Count
  • GRNQ 0
  • TXMD 0
  • Target Price
  • GRNQ N/A
  • TXMD N/A
  • AVG Volume (30 Days)
  • GRNQ 826.1K
  • TXMD 506.6K
  • Earning Date
  • GRNQ 11-12-2025
  • TXMD 11-12-2025
  • Dividend Yield
  • GRNQ N/A
  • TXMD N/A
  • EPS Growth
  • GRNQ N/A
  • TXMD N/A
  • EPS
  • GRNQ N/A
  • TXMD N/A
  • Revenue
  • GRNQ $3,256,679.00
  • TXMD $2,559,000.00
  • Revenue This Year
  • GRNQ N/A
  • TXMD $427.09
  • Revenue Next Year
  • GRNQ N/A
  • TXMD N/A
  • P/E Ratio
  • GRNQ N/A
  • TXMD N/A
  • Revenue Growth
  • GRNQ N/A
  • TXMD 156.93
  • 52 Week Low
  • GRNQ $0.80
  • TXMD $0.70
  • 52 Week High
  • GRNQ $2.50
  • TXMD $2.44
  • Technical
  • Relative Strength Index (RSI)
  • GRNQ 47.62
  • TXMD 59.44
  • Support Level
  • GRNQ $1.25
  • TXMD $1.20
  • Resistance Level
  • GRNQ $1.47
  • TXMD $1.37
  • Average True Range (ATR)
  • GRNQ 0.11
  • TXMD 0.12
  • MACD
  • GRNQ -0.00
  • TXMD 0.02
  • Stochastic Oscillator
  • GRNQ 40.66
  • TXMD 29.85

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: